JY509 Universal NK Cell Injection for the Treatment of Relapsed/Refractory Pediatric B-ALL

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
JY509 Universal NK Cell Injection for the Treatment of Relapsed/Refractory Pediatric B-ALL	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Not yet recruiting	Early phase 1	2026-02-12		NCT07406178

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institute of Hematology & Blood Diseases Hospital, China	285

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials